---
title: "Kyverna Therapeutics, Inc. (KYTX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/KYTX.US.md"
symbol: "KYTX.US"
name: "Kyverna Therapeutics, Inc."
industry: "Biotechnology"
---

# Kyverna Therapeutics, Inc. (KYTX.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [kyvernatx.com](https://kyvernatx.com) |

## Company Profile

Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, an...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.82 | 289/604 | - | - | - |
| PB | 2.99 | 222/604 | 2.36 | 0.87 | 0.40 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-06T05:00:00.000Z

Total Analysts: **6**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 4 | 67% |
| Overweight | 2 | 33% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 8.31 |
| Highest Target | 33.00 |
| Lowest Target | 20.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/KYTX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/KYTX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/KYTX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.